Neptune Technologies & Bioresources Inc Total Liabilities 2009-2019 | NEPT

Neptune Technologies & Bioresources Inc total liabilities from 2009 to 2019. Total liabilities can be defined as the total value of all possible claims against the corporation.
Neptune Technologies & Bioresources Inc Annual Total Liabilities
(Millions of US $)
2019 $16
2018 $9
2016 $30
2015 $30
2015 $
2014 $36
2014 $
2013 $11
2013 $
2012 $12
2012 $
2011 $9
2011 $
2010 $9
2010 $
2009 $8
2009 $
Neptune Technologies & Bioresources Inc Quarterly Total Liabilities
(Millions of US $)
Q1 2019 $14
Q4 2019 $16
Q3 2018 $10
Q2 2018 $10
Q1 2018 $11
Q3 2016 $29
Q2 2016 $28
Q1 2016 $28
Q4 2016 $28
Q4 2016
Q3 2015 $17
Q2 2015 $18
Q1 2015 $20
Q4 2015 $23
Q3 2014 $25
Q2 2014 $33
Q1 2014 $30
Q4 2014 $36
Q3 2013 $15
Q2 2013 $13
Q1 2013 $12
Q4 2013 $11
Q4 2013
Q3 2012 $19
Q2 2012 $17
Q1 2012 $16
Q4 2012 $12
Q3 2011 $9
Q2 2011 $10
Q1 2011 $11
Q4 2011 $9
Q3 2010 $8
Q2 2010 $9
Q1 2010 $9
Q4 2010 $9
Q3 2009 $9
Q2 2009 $10
Q1 2009 $8
Q4 2009 $8
Q3 2008
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.360B $0.018B
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $149.167B 20.94
Abbott Laboratories (ABT) United States $147.719B 27.77
Stryker (SYK) United States $82.752B 28.62
Boston Scientific (BSX) United States $60.302B 29.25
Baxter (BAX) United States $44.623B 27.06
EssilorLuxottica Societe Anonyme (ESLOY) France $31.677B 0.00
Zimmer Biomet Holdings (ZBH) United States $29.159B 18.66
Lonza Group Ag (LZAGY) Switzerland $25.836B 0.00
Coloplast (CLPBY) Denmark $25.785B 41.16
Terumo (TRUMY) Japan $23.720B 27.27
Smith & Nephew SNATS (SNN) United Kingdom $20.893B 0.00
ResMed (RMD) United States $19.328B 36.86
Sunny Optical Technology (SNPTF) China $16.573B 0.00
Bio-Rad Laboratories (BIO) United States $10.288B 55.15
Insulet (PODD) United States $9.390B 556.43
Canopy Growth (CGC) Canada $8.891B 0.00
Perrigo (PRGO) Ireland $7.516B 13.85
William Demant Holdings (WILYY) Denmark $7.386B 0.00
Hill-Rom Holdings (HRC) United States $7.032B 20.96
Haemonetics (HAE) United States $6.572B 49.59
GN STORE NORD (GNNDY) Denmark $5.570B 28.78
Aurora Cannabis (ACB) Canada $5.122B 0.00
Shandong Weigao Medical Polymer (SHWGF) China $4.296B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.982B 0.00
Neogen (NEOG) United States $3.929B 65.23
NuVasive (NUVA) United States $3.473B 27.68
ICU Medical (ICUI) United States $3.302B 21.42
Hutchison China MediTech (HCM) China $2.696B 0.00
Quidel (QDEL) United States $2.660B 26.42
Agios Pharmaceuticals (AGIO) United States $2.133B 0.00
National Vision Holdings (EYE) United States $1.958B 42.25
Cardiovascular Systems (CSII) United States $1.782B 0.00
Aphria (APHA) $1.546B 0.00
VAREX IMAGING (VREX) United States $1.100B 25.34
Lantheus Holdings (LNTH) United States $1.024B 26.92
AtriCure (ATRC) United States $0.993B 0.00
Phibro Animal Health (PAHC) United States $0.907B 14.75
Omeros (OMER) United States $0.898B 0.00
NanoString Technologies (NSTG) United States $0.863B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.775B 19.77
PetIQ (PETQ) United States $0.768B 18.15
Cerus (CERS) United States $0.748B 0.00
LeMaitre Vascular (LMAT) United States $0.699B 41.41
MacroGenics (MGNX) United States $0.630B 0.00
Surmodics (SRDX) United States $0.628B 119.36
Quanterix (QTRX) United States $0.610B 0.00
TG Therapeutics (TGTX) United States $0.573B 0.00
OraSure Technologies (OSUR) United States $0.472B 21.83
Meridian Bioscience (VIVO) United States $0.422B 13.16
BioLife Solutions (BLFS) United States $0.394B 129.63
Utah Medical Products (UTMD) United States $0.364B 26.64
Owens & Minor (OMI) United States $0.353B 10.59
Zynex (ZYXI) United States $0.324B 34.45
United Health Products (UEEC) United States $0.258B 0.00
Bovie Medical (APYX) United States $0.249B 0.00
Rockwell Medical (RMTI) United States $0.209B 0.00
Vapotherm (VAPO) United States $0.180B 0.00
Cytosorbents (CTSO) United States $0.179B 0.00
Chimerix (CMRX) United States $0.150B 0.00
Fonar (FONR) United States $0.143B 10.20
Female Health (VERU) United States $0.128B 0.00
Chembio Diagnostics (CEMI) United States $0.125B 0.00
United-Guardian (UG) United States $0.087B 20.48
Nephros (NEPH) United States $0.065B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.054B 0.00
Surface Oncology (SURF) United States $0.054B 0.00
ImmuCell (ICCC) United States $0.042B 0.00
Trinity Biotech (TRIB) Ireland $0.033B 0.00
Senestech (SNES) United States $0.028B 0.00
GUARDION HEALTH (GHSI) United States $0.019B 0.00
Capricor Therapeutics (CAPR) United States $0.012B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.011B 0.00
Valeritas Holdings (VLRX) United States $0.009B 0.00
Akers Biosciences Inc (AKER) United States $0.006B 0.00
NeuroMetrix (NURO) United States $0.004B 0.00